The clinicopathological characteristics and differential diagnosis of histiocytosis

<p>The histiocytosis is divided into Langerhans' cell histiocytosis (histiocytosis X) and non-Langerhans' cell histiocytosis (NLCH). The former mainly occurs in lymphatic hematopoietic tissue and often involves central nervous system (CNS). The latter includes Rosai-Dorfman diseas...

Full description

Bibliographic Details
Main Author: Shi-zhu YU
Format: Article
Language:English
Published: Tianjin Huanhu Hospital 2015-04-01
Series:Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:
Online Access:http://www.cjcnn.org/index.php/cjcnn/article/view/1169
Description
Summary:<p>The histiocytosis is divided into Langerhans' cell histiocytosis (histiocytosis X) and non-Langerhans' cell histiocytosis (NLCH). The former mainly occurs in lymphatic hematopoietic tissue and often involves central nervous system (CNS). The latter includes Rosai-Dorfman disease (RDD), hemophagocytic lymphohistiocytosis (HLH), Erdheim-Chester disease (ECD), juvenile xanthogranuloma (JXG) and xanthoma disseminatum (XD), choroid plexus xanthogranuloma (CPXG), choroid plexus xanthoma (CPX), which may occur in lymphatic hematopoietic tissue and (or) CNS. This review has briefly introduced the clinicopathological characteristics and differential diagnosis of the above lesions. The incidence of these diseases is low in CNS, so they are often ignored, misdiagnosed and impertinently treated by neurosurgeons and pathologists. Therefore, understanding their clinical and pathological characteristics is conducive to improve the diagnosis and therapy.</p><p> </p><p><strong>DOI: </strong>10.3969/j.issn.1672-6731.2015.04.002</p>
ISSN:1672-6731